Life Sciences
WIT’s Life Sciences practice focuses on building teams of world-renowned testifying experts from academia, industry, and government to address the needs of the pharmaceutical and life sciences industries.
WIT regularly takes on bet-the-company litigation involving the pharmaceutical and life sciences industries. We stay ahead of the curve of the medical, legal, and technical issues at the core of these disputes so that we have the best people to support our clients’ needs as they assess and address their litigation and regulatory risks.
- Exclusionary Practices
- Life-cycle Management Strategies or “Product Hopping”
- Mergers & Acquisitions
- Monopolization and Collusion
- “Pay for Delay”
- Predatory and Discriminatory Pricing
- Price-fixing Claims
- Reverse payment settlements
WIT provides leading experts for a wide variety of antitrust and competition disputes related to exclusionary practices, price-fixing allegations, and monopolization and collusion claims.
- Biologics Price Competition and Innovation Act (BPCIA)
- Cannabis and Hemp
- Clinical Trials
- New Drugs
- Product Labeling and Advertising
- Safety Monitoring
- Vaccines
WIT represents a strong team of scientists, many of whom have direct experience reviewing generic drug and biosimilar submissions working at the FDA.
- Anti-kickback Statutes
- Medicare/Medicaid Reimbursement and Billing Issues
- Off-label Marketing
- Physician Kickbacks
- Stark Claims
- Upcoding
WIT provides leading experts for False Claims Act cases, qui tam actions, Stark Law, and Anti-Kickback Statute investigations.
- Biopharmaceuticals and Immunotherapy
- Biosimilars
- Hatch-Waxman ANDA
- Medical Device Patents
- Reasonable Royalties
- Supply Chain
- Trade Secret Disputes
WIT’s life sciences experts have decades of experience in chemistry, biochemistry, biotechnology, physics, engineering, genetics, and neuroscience. They regularly assist our clients in cases involving supply chain disruption, medical device patents, and the protection of trade secrets.
- Class Actions
- Consumer Protection Statutes
- Failure to Warn
- MDL Proceedings
- Medical Devices and Medical Products
- Pharmaceutical Mass Tort
WIT has been involved in many of the largest product liability cases in recent history including on behalf of dozens of parties in the Opioid MDL.
WIT represents esteemed academics, former regulators, and industry veterans experienced in the pharmaceutical, biotechnology, and medical device industries. Our expert teams are ready to support you through every stage of the litigation. A representative sample of our experts’ specialties:
- Bacteriology
- Biomedical Engineering
- Biostatistics
- Biotechnology
- Drug Licensing
- Epidemiology
- FCA/Qui Tam
- Former FDA, CDC, HHS, NIH, NCPDCID, NIAID
- Formulations
- Genetics
- Healthcare Compliance
- Healthcare Economists
- Materials Science
- Medical Doctors
- Microbiology
- Outbreak/Pandemic
- Pharmacology
- Pharmacokinetics & PBPK Modeling
- Pharmacodynamics
- Pharmaceutical Marketing
- Pharmacy Executives
- Proteomics
- Toxicology
- Virology